PS, Y., CL, C., CP, H., YH, L., & KH, T. (2018). An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin. Dove Medical Press.
Style de citation Chicago (17e éd.)PS, Yang, Chen CL, Hou CP, Lin YH, et Tsui KH. An Open-label, Prospective Interventional Study of the Tolerability and Efficacy of 0.4 Mg Oral Tamsulosin Oral Controlled Absorption System in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia Who Are Unsatisfied with Treatment with 0.2 Mg Tamsulosin. Dove Medical Press, 2018.
Style de citation MLA (8e éd.)PS, Yang, et al. An Open-label, Prospective Interventional Study of the Tolerability and Efficacy of 0.4 Mg Oral Tamsulosin Oral Controlled Absorption System in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia Who Are Unsatisfied with Treatment with 0.2 Mg Tamsulosin. Dove Medical Press, 2018.